Topical treatment of acne vulgaris.
For the relief of mild to moderate papular-pustular acne of the facial area. For the topical treatment of papulopustular rosacea.
Allergan announced the approval of Rhofade cream (oxymetazoline HCI cream 1.0%) by the U.S. FDA for the topical treatment of...
Sol-Gel Technologies, Ltd. announced the FDA approval of its drug product, Epsolay, a proprietary cream formulation of benzoyl peroxide, 5%, for the treatment of inflammatory lesions of rosacea in adults.
Dipexium Pharmaceuticals, Inc. announced that the OneStep-1 and OneStep-2 Phase III clinical trials of Locilex (pexiganan cream 0.8%) in patients...
Galderma Laboratories, L.P. has announced on 24 December 2014 the FDA approved Soolantra (ivermectin) Cream, 1% for the once-daily topical...
LEO Pharma has entered into a definitive agreement to buy Bayer�s global prescription dermatology unit. The portfolio to be acquired...